Xalacom

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2015
012320042015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
PURPOSE We investigated the transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit… (More)
Is this relevant?
2013
2013
The purpose of this case is to present the use of pattern electroretinogram (PERG) in the early diagnosis of normal-tension… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2011
2011
PURPOSE To evaluate the safety of fixed-combination latanoprost/timolol (Xalacom) in patients requiring additional intraocular… (More)
Is this relevant?
2011
2011
Preservatives in eye drops, especially benzalkonium chloride (BAC), may act as cytotoxic; furthermore, it may cause the… (More)
Is this relevant?
2008
2008
OBJECTIVE The aim of this study was to confirm randomized clinical trial results showing that a fixed timolol/travoprost… (More)
Is this relevant?
2008
2008
Once-daily administration of fixed-combination latanoprost and timolol in patients with open-angle glaucoma and ocular… (More)
  • figure 1
Is this relevant?
Review
2008
Review
2008
OBJECTIVE To assess the cost-efficacy of three fixed-combination glaucoma treatments currently available in Spain [bimatoprost… (More)
Is this relevant?
2005
2005
OBJECTIVE To compare the costs of the new fixed combinations for glaucoma medical therapy. METHODS The studied drugs were… (More)
Is this relevant?
2005
2005
PURPOSE To evaluate the daily cost of antiglaucoma eyedrops and the economic impact related to the minimal wage; to compare the… (More)
Is this relevant?
Review
2004
Review
2004
The primary standard therapy in patients with open-angle glaucoma and ocular hypertension is carried out by means of monotherapy… (More)
Is this relevant?